Gas chromatographic determination of residual acridine and iminodibenzyl in dibenzazepine drugs and related compounds

• Autorzy: Syed A. A. , Silwadi M. F. , Kirumakki S. R. , Narasimiah N.
• Języki publikacji: EN

Abstrakty

EN

A new, selective, packed-column gas-chromatographic method has been developed for the determination of acridine in the presence of imino-dibenzyl and iminostilbene. The method involves dissolution of acridine and iminodibenzyl or iminostilbene in benzyl alcohol and injection of this solution into a 2 m × 2 mm i.d. glass column packed with 4% OV-225 on 80-100 mesh Chromosorb WAW-DMCS. Under these conditions acridine, iminodibenzyl, and iminostilbene are eluted after 2.37, 3.49, and 4.76 min, respectively. The method is reproducible and the relative standard deviation for 10 repeated injections of 2 žL is <2%. The procedure has been success-fully employed for the determination of the amounts of iminodibenzyl residues in trimipramine maleate, imipramine hydrochloride, clomipramine hydrochloride, and opipramol formulations and in samples of these compounds subjected to forced degradation.

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2002
• Tom: No. 12
• Strony: 80--88
• Opis fizyczny: Bibliogr. 36 poz., rys.

Twórcy

autor

Syed A. A.

• Department of Studies in Chemistry, University of Mysore, Manasagangothri, Mysore-570 006, India

autor

Silwadi M. F.

• Department of Studies in Chemistry, University of Mysore, Manasagangothri, Mysore-570 006, India

autor

Kirumakki S. R.

• St. Joseph’s P.G. Centre, 33, Langford Road, Bangalore-560 027, India

autor

Narasimiah N.

• St. Joseph’s P.G. Centre, 33, Langford Road, Bangalore-560 027, India

Bibliografia

• [1] R. F. Deorge, in: Wilson and Gisvold (Eds), Textbook of Organic Medical and Pharmaceutical Chemistry, 8th Edn, Lippincott, Philadelphia, 1982; p. 392
• [2] L. Lachman, P. Deluca, and M. J. Akers, in: L. Lachman, H. A. Liberman, and J. L. Kanig (Eds) Theory and Practice of Industrial Pharmacy, 3rd Edn, Varghese Publishing House, India, 1987, pp. 760–803
• [3] K. Adank and W. Hammerschmidt, Chimia, 18, 361 (1964)
• [4] K. Adank and Th. Schmidt, Chimia, 23, 299 (1969)
• [5] M. Claeys, G. Muscettola, and S. Markey, Biomed. Mass Spec., 3, 110 (1976)
• [6] H. Schramek, J. Riethmann, and J. Kallen, Swiss Patent, 442, 319 (1968); Chem. Abs., 69, p. 35976z (1968)
• [7] British Pharmacopoeia, H. M. Stationery Office, London, pp. 309, 587–588 (1988)
• [8] M. P. San-Andres, D. Sicilia, and D. Perez-Bendito, J. Pharm. Sci., 87, 821 (1998)
• [9] E. J. Greenhow and O. Ladipo, Anal. Chim. Acta, 172, 387 (1985)
• [10] E. Bishop and W. Hussein, Analyst, 109, 73 (1984)
• [11] E. S. Smotkin, G. B. Martin, and G. A. Rechnitz, Anal. Lett., 24, 797 (1991)
• [12] M. Khodari, Electroanalysis, 5, 521 (1993)
• [13] I. Biryol, B. Uslu, and Z. Kucukyavuz, J. Pharm. Biomed. Anal., 15, 371 (1996)
• [14] H. Hopkala and G. Misztal, Pharmazie, 51, 96 (1996)
• [15] P. Umapathi and P. Parimoo, J. Pharm. Biomed. Anal., 13, 1003 (1995)
• [16] J. M. Garcia-Fraga, A. I. Jimenez-Abizanda, F. Jimenez-Moreno, and J. J. Arias Leon, J. Pharm. Biomed. Anal., 9, 109 (1991)
• [17] S. A. Hussein, M. E. El-Kommos, H. Y. Hassan, I. Abdel-Maboud, and A. M. I. Mohammed, Talanta, 36, 941 (1989)
• [18] S. Suzuki, H. Nakazawa, M. Fujita, S. Ono, M. Suzuki, S. Takitani, M. Sonoda, and Y. Sakagishi, Anal. Chim. Acta, 261, 39 (1992)
• [19] H. A. Mohamed, H. Y. Hassan, A. Mohammed, and S. A. Hussein, Anal. Lett., 25, 63 (1992)
• [20] E. M. Elnemma, F. M. Elzawawy, and S. S. M. Hassan, Mikrochim. Acta, 110, 79 (1993)
• [21] T. Perez-Ruiz, C. Martinez-Lozano, A. Sanz, and C. Alonso, Talanta, 41, 1523 (1994)
• [22] S. L. Bhongade, P. A. Thakurdesai, and A. V. Kasture, Indian Drugs, 31, 219 (1994)
• [23] P. Nagaraja, M. F. Silwadi, and A. A. Syed, Chimica Acta Turcica, 27, 21 (1999)
• [24] P. Nagaraja, M. F. Silwadi, and A. A. Syed, Anal. Lett., 33, 2913 (2000)
• [25] P. Nagaraja, M. F. Silwadi, and A. A. Syed, Mikrochim. Acta, 135, 185 (2000)
• [26] T. Perez-Ruiz, C. Martinez-Lozano, V. Tomas, and C. Sidrach, C. Analyst, 120, 1103 (1995)
• [27] A. Goldnik, M. Gajewska, E. Dołęgowska, and B. Pacuła, Acta. Pol. Pharm., 48, 3 (1991)
• [28] H. L. Rau, A. R. Aroor, and P. G. Rao, Indian J. Pharm. Sci., 53, 31 (1991)
• [29] N. Sistovaris, E. E. Dagrosa, and A. Keller, J. Chromatogr., 277, 273 (1983)
• [30] A. M. Bourgerolle, J. L. Chabard, M. Jbilou, H. Bargnoux, J. Petit, and J. A. Berger, J. Chromatogr., 434, 232 (1988)
• [31] F. Pommier, A. Sioufi, and J. Godbillon, J. Chromatogr. B., 703, 147 (1997)
• [32] J. Hallbach, H. Vogel, P. W. Boogaard, and W. G. Guder, Clin. Lab., 45, 191 (1999)
• [33] D. J. Sequeira and H. W. Strobel, J. Chromatogr. B., 673, 251 (1995)
• [34] L. P. Hackett, L. J. Dusci, and K. F. Ilett, Ther. Drug Monit., 20, 30 (1998)
• [35] R. Theurillat and W. Thormann, J. Pharm. Biomed. Anal., 18, 751 (1998)
• [36] H. Weigmann, S. Hartter, and C. Hiemke, J. Chromatogr. B., 710, 227 (1998)